科华生物股价下跌3.44% CRP检测试剂盒获五年期注册证

Core Viewpoint - The stock price of Kehua Bio is reported at 7.58 yuan, reflecting a decrease of 0.27 yuan from the previous trading day, with a trading range of 5.48% and a transaction amount of 319 million yuan [1] Company Overview - Kehua Bio's main business includes the research and production of in vitro diagnostic reagents and medical testing instruments, with product lines covering immunodiagnostics, biochemical diagnostics, and molecular diagnostics, primarily used in medical institution laboratory testing [1] Regulatory Update - The company has recently obtained a medical device registration certificate for the C-reactive protein testing kit from the Shanghai Municipal Medical Products Administration, valid until August 6, 2030 [1] Financial Metrics - The latest data indicates that the company's total market capitalization is 3.899 billion yuan, with a price-to-earnings ratio of -18.30 times [1] Capital Flow - On the trading day, the net outflow of main funds for the stock was 18.32 million yuan, while the cumulative net inflow over the past five trading days was 15.94 million yuan [1]